Please use this identifier to cite or link to this item:
Title: Monocyte cell membrane-derived nanoghosts for targeted cancer therapy
Authors: Krishnamurthy, Sangeetha
Gnanasammandhan, M. K.
Xie, Chen
Huang, K.
Cui, M. Y.
Chan, J. M.
Keywords: Serum stability
Issue Date: 2016
Source: Krishnamurthy, S., Gnanasammandhan, M. K., Xie, C., Huang, K., Cui, M. Y., & Chan, J. M. (2016). Monocyte cell membrane-derived nanoghosts for targeted cancer therapy. Nanoscale, 8(13), 6981-6985. doxo
Series/Report no.: Nanoscale
Abstract: Core-shell type ‘nanoghosts’ were synthesized with a drug-loaded biodegradable PLGA core and a monocyte cell membrane-derived shell. The nanoghosts were monodisperse with an average size <200 nm, and showed good serum stability for 120 h dox0rubicin loaded nanoghosts showed greater cellular uptake and cytotoxicity compared to non-coated nanoparticle controls in metastatic MCF-7 breast cancer cell lines.
ISSN: 2040-3372
DOI: 10.1039/C5NR07588B
Schools: School of Chemical and Biomedical Engineering 
Rights: © 2016 The Royal Society of Chemistry. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Journal Articles

Files in This Item:
File Description SizeFormat 
Monocyte cell membrane-derived nanoghosts for targeted cancer therapy.pdf1.11 MBAdobe PDFThumbnail

Citations 5

Updated on Jun 12, 2024

Web of ScienceTM
Citations 5

Updated on Oct 31, 2023

Page view(s)

Updated on Jun 20, 2024

Download(s) 20

Updated on Jun 20, 2024

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.